CB Insights
Technology Market Intelligence
Technology Market Intelligence
The Redx Pharma group is focused on early stage drug discovery and development programmes at sites in Liverpool (Redx Oncology) and at Alderley Park, Cheshire (Redx Anti-infectives). Fulfilling the needs of large and mid-sized pharma companies for ne...Show all
Company (IPO / Went public)
Phone: 0151 706 4747
Duncan Building, Royal Liverpool Univ. Hospital
Daulby Street
Liverpool, L69 3GA
England, United Kingdom
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors | Jan 10, 2019 | Oct 06, 2020 | Patent |
| N-pyridinyl acetamide derivatives as inhibitors of the wnt signaling pathway | Jul 17, 2018 | Oct 06, 2020 | Patent |
| Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer | Sep 16, 2016 | Apr 07, 2020 | Patent |
| Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds | Feb 08, 2017 | Nov 26, 2019 | Patent |
| Antibacterial compounds | Apr 10, 2015 | Aug 20, 2019 | Patent |
